US Stock MarketDetailed Quotes
KZR Kezar Life Sciences
- 0.805
- +0.015+1.89%
Close Apr 26 16:00 ET
- 0.808
- +0.003+0.36%
Post 19:38 ET
58.60MMarket Cap-574P/E (TTM)
0.814High0.780Low496.30KVolume0.800Open0.790Pre Close395.70KTurnover0.95%Turnover RatioLossP/E (Static)72.80MShares3.13052wk High0.31P/B42.24MFloat Cap0.67552wk Low--Dividend TTM52.48MShs Float36.327Historical High--Div YieldTTM4.28%Amplitude0.675Historical Low0.797Avg Price1Lot Size
Kezar Life Sciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -38.74%-81.65M | -19.50%-18.98M | -23.50%-20.21M | -62.54%-21.6M | -56.68%-20.86M | -38.67%-58.85M | -43.34%-15.88M | -64.36%-16.36M | -1.87%-13.29M | -59.32%-13.31M |
| Net income from continuing operations | -49.28%-101.87M | -77.44%-32.26M | -29.45%-23.1M | -50.17%-24.31M | -38.54%-22.2M | -24.91%-68.24M | -27.93%-18.18M | -23.41%-17.85M | -24.88%-16.19M | -23.32%-16.02M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Depreciation and amortization | 4.20%1.07M | 198.94%280K | -39.30%278K | -42.23%249K | -37.89%259K | -32.25%1.02M | -173.13%-283K | 21.16%458K | 15.55%431K | 12.10%417K |
| Other non cash items | 6.25%238K | -6.06%62K | 11.54%58K | 11.32%59K | 11.32%59K | 146.15%224K | --66K | --52K | --53K | --53K |
| Change In working capital | 205.54%4.71M | 14,287.93%8.35M | -5.63%-2.31M | 117.64%199K | -27.10%-1.53M | -463.70%-4.46M | -87.99%58K | -218.55%-2.19M | 61.42%-1.13M | -165.99%-1.2M |
| -Change in prepaid assets | 161.91%3.58M | 1,095.20%5.39M | 145.17%1.83M | 25.16%-827K | -3,173.26%-2.82M | -650.62%-5.79M | -177.99%-542K | -1,175.33%-4.05M | -10.39%-1.11M | -108.78%-86K |
| -Change in payables and accrued expense | 249.89%6.35M | 379.50%959K | 35.00%2.94M | 301.46%1.1M | 262.23%1.35M | 49.06%1.81M | 233.33%200K | 25.45%2.17M | 116.47%274K | -176.65%-834K |
| -Change in other working capital | -974.90%-5.22M | -1,352.00%-5.01M | ---- | ---- | 76.33%-67K | 53.36%-486K | --400K | ---- | ---- | ---283K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -38.74%-81.65M | -19.50%-18.98M | -23.50%-20.21M | -62.54%-21.6M | -56.68%-20.86M | -38.67%-58.85M | -43.34%-15.88M | -64.36%-16.36M | -1.87%-13.29M | -59.32%-13.31M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 183.21%76.05M | 421.88%27.88M | 175.17%18.57M | 774.37%13.2M | 127.53%16.39M | -221.31%-91.39M | 89.50%-8.66M | -164.20%-24.71M | -90.71%1.51M | -8,565.65%-59.53M |
| Net PPE purchase and sale | -14.39%-1.81M | 99.71%-1K | 78.28%-131K | -656.04%-1.38M | 34.00%-297K | -399.37%-1.58M | -28.95%-343K | -2,219.23%-603K | -658.33%-182K | ---450K |
| Net investment purchase and sale | 186.68%77.85M | 435.16%27.88M | 177.60%18.71M | 761.64%14.58M | 128.25%16.69M | -219.30%-89.81M | 89.88%-8.32M | -162.59%-24.11M | -89.60%1.69M | -8,500.15%-59.08M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 183.21%76.05M | 421.88%27.88M | 175.17%18.57M | 774.37%13.2M | 127.53%16.39M | -221.31%-91.39M | 89.50%-8.66M | -164.20%-24.71M | -90.71%1.51M | -8,565.65%-59.53M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.50%638K | -88.34%59K | -76.76%43K | -99.51%382K | -99.68%154K | 13.57%127.86M | -99.49%506K | -91.64%185K | 27,673.76%78.32M | 355.03%48.85M |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --0 | 28.78%-579K | -76.76%43K | -99.51%382K | -99.68%154K | 25.33%126.54M | -100.93%-813K | -91.64%185K | 27,673.76%78.32M | 355.03%48.85M |
| Proceeds from stock option exercised by employees | -51.63%638K | ---- | ---- | ---- | ---- | -36.71%1.32M | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.50%638K | -88.34%59K | -76.76%43K | -99.51%382K | -99.68%154K | 13.57%127.86M | -99.49%506K | -91.64%185K | 27,673.76%78.32M | 355.03%48.85M |
| Net cash flow | ||||||||||
| Beginning cash position | -35.66%40.46M | -58.89%26.5M | -73.33%28.11M | -7.14%36.13M | -35.66%40.46M | 196.22%62.88M | 12.89%64.45M | 299.47%105.39M | 69.84%38.91M | 196.22%62.88M |
| Current changes in cash | 77.83%-4.96M | 137.26%8.96M | 96.12%-1.59M | -112.04%-8.02M | 82.02%-4.32M | -153.66%-22.38M | -515.59%-24.04M | -232.99%-40.88M | 1,808.32%66.54M | -1,519.22%-24M |
| Effect of exchange rate changes | 95.92%-2K | -7.32%38K | 54.90%-23K | 92.19%-5K | -148.00%-12K | 2.00%-49K | 925.00%41K | -70.00%-51K | -392.31%-64K | 327.27%25K |
| End cash Position | -12.27%35.49M | -12.27%35.49M | -58.89%26.5M | -73.33%28.11M | -7.14%36.13M | -35.66%40.46M | -35.66%40.46M | 12.89%64.45M | 299.47%105.39M | 69.84%38.91M |
| Free cash flow | -38.12%-83.46M | -16.98%-18.98M | -19.91%-20.34M | -70.56%-22.98M | -53.71%-21.16M | -41.33%-60.42M | -43.00%-16.23M | -69.97%-16.96M | -3.08%-13.47M | -64.70%-13.76M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg